Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lennard

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
DNA and Cell Biology|January 1, 1996
Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphismC Szumlanski, D Otterness, C Her, et al.
European Journal of Immunology|July 20, 2016
Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factorMara L Lennard Richard, Danielle Brandon, Ning Lou, et al.
BMC Molecular Biology|February 3, 2007
Characterization of an Oct1 orthologue in the channel catfish, Ictalurus punctatus: a negative regulator of immunoglobulin gene transcription?Mara L Lennard, Jun-ichi Hikima, David A Ross, et al.
British Journal of Cancer|September 1, 1994
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma GroupG H Jackson, A L Lennard, P R Taylor, et al.
Leukemia & Lymphoma|March 14, 1998
Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UKG H Jackson, A Wood, P R Taylor, et al.
Clinical Pharmacology and Therapeutics|July 1, 1997
Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphismsD Otterness, C Szumlanski, L Lennard, et al.
Blood|March 4, 2010
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantationMichal Sieniawski, Nithia Angamuthu, Kathryn Boyd, et al.
Molecular Immunology|December 8, 2009
Differential transcriptomic responses of Biomphalaria glabrata (Gastropoda, Mollusca) to bacteria and metazoan parasites, Schistosoma mansoni and Echinostoma paraensei (Digenea, Platyhelminthes)Coen M Adema, Patrick C Hanington, Cheng-Man Lun, et al.
Hematological Oncology|January 1, 1989
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease. A prospective study on behalf of the East of Scotland and Newcastle Lymphoma Group (ESNLG)A L Lennard, S J Proctor, A A Dawson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)S J Proctor, M Mackie, A Dawson, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
DNA and Cell Biology|January 1, 1996
Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphismC Szumlanski, D Otterness, C Her, et al.
European Journal of Immunology|July 20, 2016
Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factorMara L Lennard Richard, Danielle Brandon, Ning Lou, et al.
BMC Molecular Biology|February 3, 2007
Characterization of an Oct1 orthologue in the channel catfish, Ictalurus punctatus: a negative regulator of immunoglobulin gene transcription?Mara L Lennard, Jun-ichi Hikima, David A Ross, et al.
British Journal of Cancer|September 1, 1994
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma GroupG H Jackson, A L Lennard, P R Taylor, et al.
Leukemia & Lymphoma|March 14, 1998
Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UKG H Jackson, A Wood, P R Taylor, et al.
Clinical Pharmacology and Therapeutics|July 1, 1997
Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphismsD Otterness, C Szumlanski, L Lennard, et al.
Blood|March 4, 2010
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantationMichal Sieniawski, Nithia Angamuthu, Kathryn Boyd, et al.
Molecular Immunology|December 8, 2009
Differential transcriptomic responses of Biomphalaria glabrata (Gastropoda, Mollusca) to bacteria and metazoan parasites, Schistosoma mansoni and Echinostoma paraensei (Digenea, Platyhelminthes)Coen M Adema, Patrick C Hanington, Cheng-Man Lun, et al.
Hematological Oncology|January 1, 1989
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease. A prospective study on behalf of the East of Scotland and Newcastle Lymphoma Group (ESNLG)A L Lennard, S J Proctor, A A Dawson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)S J Proctor, M Mackie, A Dawson, et al.
Pageof 9